Meghan Delaney, D.O., M.P.H., is the chief of the Division of Pathology and Lab Medicine and director of Transfusion Medicine. She is the professor of Pathology and Pediatrics and the George Washington University. Dr. Delaney serves as a member of the Board of Directors for the Association for the Advancement of Blood & Biotherapies (AABB), a scientific member of the BEST Collaborative and member of the American Board of Pathology Test Development and Advisory Committee.
Dr. Delaney’s scholarly focus is in clinical pathology, laboratory management, transfusion medicine, pediatric transfusion medicine and immunohematology. She has over 100 peer reviewed publications and lectures nationally and internationally. In global health, Dr. Delaney focuses on improving access to safe blood transfusion in developing nations. She serves as the Chair of NIH’s BLOODSAFE Program that aims to improve access to safe blood in Sub Saharan Africa.
The British Blood Transfusion Society (BBTS) recognized Dr. Delaney with the 2021 James Blundell Award. This is the most prestigious award given by the BBTS. Introduced in 1984, this award is given to recipients for original research resulting in an important and significant contribution to the body of medical and or scientific knowledge within the field of blood transfusion.